characterization of a new malignant human t-cell l...[eur j haematol. 1990] - pubmed result
Post on 30-May-2018
214 Views
Preview:
TRANSCRIPT
-
8/14/2019 Characterization of a New Malignant Human T-Cell l...[Eur J Haematol. 1990] - PubMed Result
1/1
Search PubMedPubMed for Go
Clear
PMID: 2307225 [PubMed - indexed for MEDLINE]
Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid.
Helgestad J, Pettersen R, Storm-Mathisen I, Schjerven L, Ulrich K, Smeland EB, Egeland T,Srskaard D, Brgger A, Hovig T, et al.
Department of Pediatric Research, National Hospital of Norway, Oslo.
A new malignant human T-cell line-labelled PFI-285-has been isolated from a boy with malignant lymphoma.
Morphologically, the cells had characteristics of malignant lymphoid cells. The cells presented surface antigens
as early cortical lymphocytes and proliferated non-adherently as single cells, independent of T-cell growth factor
(IL-2), in liquid culture. The cells had undetectable levels of receptors for IL-2, were not clonogenic in soft agar,
but did form tumors in nude mice. Their establishment and continuous growth in vitro was dependent on the
number of cells inoculated and on the growth medium used. Cytogenetic alteration, HTLV-1 or reverse
transcriptase activity were not detected. The production of known T-cell derived lymphokines such as IL-2,
B-cell growth factor(s), alpha-interferon or granulocyte/macrophage colony stimulating or inhibiting factor(s)
was not detected. The cells had 5-8% natural killer (NK)-cell activity against NK-cell sensitive target cells
(K562) and were not sensitive for NK cells. A most unusual characteristic was the pronounced sensitivity of the
cells to ascorbic acid. Concentrations down to 50 mumol/l killed the cells within hours.
1: Eur J Haematol. 1990 Jan;44(1):9-17.
Ad
AbstractPlusAbstractPlus 2020 Sort BySort By Send toSend to
Links
AbstractPlusAbstractPlus 2020 Sort BySort By Send toSend to
Write to the Help Desk
NCBI | NLM | NIHDepartment of Health & Human Services
Privacy Statement | Freedom of Information Act | Disclaimer
All Databases PubMed Nucleotide Protein Genome Structure OMIM PMC Journals Books
Recent Activity
A service of the U.S. National Library of Medicine
and the National Institutes of HealthMy NCBI
[Sign In][Register]
Limits Preview/Index History Clipboard Details
Display Show
All: 1 Review: 0
ClearTurn Off
Characterization of a new malignant human T-cell line (PFI-285) sensitive to
ascorbic acid...
Dietary vitamins A, C, and E and selenium as risk factors for cervical
cancer.
Display Show
Related Articles
See Reviews...| See All...
Antileukemia activity of a natural killer cell line against human leukemias.
[Clin Cancer Res. 1998]
In vitro cytotoxicity and transplantation protection by autologous natural and
activated killer cells against an in vitro transformed tumorigenic fibroblast line. A[J Clin Invest. 1985]
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell
rejection without T and NK cell involvement. [J Immunol. 2000]
Review Cytotoxic cells in immunodeficient athymic mice.
[Immunopharmacol Immunotoxicol. 1994]
Review Pheno- and genotypic characteristics of human non-Hodgkin lymphoma
xenografts. [Acta Histochem Suppl. 1990]
Patient Drug Information
Source: AHFS Consumer Medication Information
Ascorbic Acid (Cecon Drops, Cenolate , Cevi-Bid , ...) Ascorbic acid is used
to prevent and treat scurvy, a disease caused by a lack of vitamin C in the body.
top related